KAVISH PATIDAR to Severity of Illness Index
This is a "connection" page, showing publications KAVISH PATIDAR has written about Severity of Illness Index.
Connection Strength
1.462
-
Controversies in terlipressin and transplantation in the United States: How do we MELD the two? Liver Transpl. 2024 Jul 01; 30(7):753-759.
Score: 0.497
-
Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study. Lancet Gastroenterol Hepatol. 2025 May; 10(5):418-430.
Score: 0.133
-
Acute kidney injury in severe alcohol-associated hepatitis treated with anakinra plus zinc or prednisone. Hepatology. 2025 Apr 01; 81(4):1256-1268.
Score: 0.127
-
Clinical characteristics and prognosis of hospitalized patients with moderate alcohol-associated hepatitis. Liver Int. 2024 01; 44(1):241-249.
Score: 0.121
-
Severe Alcohol-Associated Hepatitis Is Associated With Worse Survival in Critically Ill Patients With Acute on Chronic Liver Failure. Hepatol Commun. 2022 05; 6(5):1090-1099.
Score: 0.106
-
Practice patterns and outcomes associated with intravenous albumin in patients with cirrhosis and acute kidney injury. Liver Int. 2022 01; 42(1):187-198.
Score: 0.106
-
Associations Between Mean Arterial Pressure and Poor ICU Outcomes in Critically Ill Patients With Cirrhosis: Is 65 The Sweet Spot? Crit Care Med. 2020 09; 48(9):e753-e760.
Score: 0.097
-
Impact of acute kidney injury response on survival and liver transplant rates in hospitalized patients with cirrhosis awaiting liver transplantation: Results from the HRS-HARMONY consortium. Liver Transpl. 2024 Nov 01; 30(11):1106-1115.
Score: 0.032
-
Cystatin C and the difference between cystatin C and serum creatinine: Improved metrics to predict waitlist mortality among patients with decompensated cirrhosis. Liver Transpl. 2025 Jan 01; 31(1):24-31.
Score: 0.032
-
Outcomes of patients with alcohol-associated hepatitis and acute kidney injury - Results from the HRS Harmony Consortium. Aliment Pharmacol Ther. 2024 Sep; 60(6):778-786.
Score: 0.032
-
Performance of race-neutral eGFR equations in patients with decompensated cirrhosis. Liver Transpl. 2025 Feb 01; 31(2):170-180.
Score: 0.031
-
PROMIS Profile-29 is a valid instrument with distinct advantages over legacy instruments for measuring the quality of life in chronic liver disease. Hepatology. 2023 12 01; 78(6):1788-1799.
Score: 0.029
-
Measuring Medication Use, Obstacles, and Knowledge in Individuals With Cirrhosis. Clin Gastroenterol Hepatol. 2023 Jul; 21(7):1819-1830.e5.
Score: 0.028
-
Patient-Reported Outcome Measures Modestly Enhance Prediction of Readmission in Patients with Cirrhosis. Clin Gastroenterol Hepatol. 2022 06; 20(6):e1426-e1437.
Score: 0.026
-
Bleeding After Elective Interventional Endoscopic Procedures in a Large Cohort of Patients With Cirrhosis. Clin Transl Gastroenterol. 2020 12 17; 11(12):e00288.
Score: 0.025
-
Comorbidity Burden May Be Associated with Increased Mortality in Patients with Severe Acute Liver Injury Referred for Liver Transplantation. Ann Transplant. 2020 Nov 03; 25:e926453.
Score: 0.025
-
Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease. Liver Int. 2016 Apr; 36(4):572-9.
Score: 0.018